Who Should Take GLP-1 Medications for Weight Loss

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonist medications like semaglutide have demonstrated the ability to reduce body weight by 15 to 22 percent in clinical trials when combined with lifestyle changes. However, identifying whether you're a good candidate requires understanding your medical history, metabolic profile, and individual health circumstances. PlexusDx specializes in precision medicine to match you with the right GLP-1 therapy.

BMI and Weight Loss Criteria for GLP-1 Eligibility

The FDA-approved indication for semaglutide includes adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnea. PlexusDx evaluates not just your number on the scale, but the constellation of metabolic markers and comorbidities that make GLP-1 therapy a strategic intervention.

Beyond BMI thresholds, your candidacy depends on consistent unsuccessful attempts at weight loss through diet and exercise alone over a meaningful period. Many PlexusDx patients have tried multiple approaches and plateaued, making them ideal candidates for pharmaceutical support. A detailed health intake captures this trajectory to ensure semaglutide injection or oral formulations serve a genuine clinical need.

Medical Conditions That Support GLP-1 Treatment

Type 2 diabetes management often benefits from GLP-1 therapy, which lowers blood sugar while promoting weight loss simultaneously. Patients with hypertension or dyslipidemia—particularly those struggling with visceral fat accumulation—frequently experience cardiovascular improvements alongside weight reduction. PlexusDx identifies these metabolic clusters to personalize your medication choice, whether compounded semaglutide injection at $149/month or another agent.

Polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease, and sleep apnea represent additional conditions where GLP-1 compounds address underlying pathophysiology, not merely appearance. Individuals with a family history of type 2 diabetes or early cardiovascular disease may benefit from GLP-1's preventive metabolic effects. PlexusDx evaluates your full clinical picture to confirm medical appropriateness.

Genetic and Metabolic Factors Affecting GLP-1 Response

Your genetic makeup influences how effectively you respond to GLP-1 medications. The PlexusDx Precision Peptide Genetic Test analyzes key variants in the GLP1R gene (rs6923761), GIPR pathway (rs1800437), and appetite-regulation loci like FTO (rs9939609) and MC4R (rs17782313) to reveal your peptide-pathway predispositions. These 150+ genetic insights map across 14 metabolic pathways and 49 individual peptides, helping clinicians optimize your compound and dose strategy from the outset.

Some patients carry genetic variants that predict robust semaglutide response, while others may respond better to tirzepatide's dual GIP-GLP-1 mechanism. The genetic test costs $99 as an add-on after your first month of treatment and provides data-driven guidance that traditionally required months of trial-and-error dosing. Understanding your genetic predisposition accelerates the path to your ideal weight loss velocity.

Pregnancy, Medications, and Contraindications

Pregnant individuals and those actively planning pregnancy should not use GLP-1 medications, as safety data in pregnancy remain insufficient. A history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 is an absolute contraindication due to GLP-1's effects on calcitonin-producing cells. PlexusDx screens for these conditions during the enrollment process to ensure safe, appropriate patient selection.

Certain medications—particularly insulin secretagogues or sulfonylureas—require dose adjustment when GLP-1 therapy begins to prevent hypoglycemia. Individuals with a personal history of pancreatitis must discuss this with their PlexusDx provider, as GLP-1 carries a theoretical risk. Kidney disease, particularly advanced chronic kidney disease, requires individualized assessment. PlexusDx's comprehensive intake ensures all contraindications and drug interactions are identified before starting semaglutide injection or oral alternatives.

Mental Readiness and Lifestyle Commitment

GLP-1 medications amplify the effects of structured eating and movement habits; they are not replacements for lifestyle change. Candidates should demonstrate readiness to adopt a higher-protein, lower-sugar dietary pattern and engage in regular physical activity—whether that's 150 minutes of moderate cardio weekly or resistance training. PlexusDx providers assess motivation and psychosocial readiness during consultations to maximize long-term success.

Individuals who have previously succeeded with short-term diet programs but regained weight often find GLP-1 compounds provide the metabolic support needed to maintain new habits. Those struggling with food noise, late-night eating, or binge episodes frequently report profound psychological relief as appetite signals normalize. Your PlexusDx journey includes ongoing behavioral support to sustain the weight loss achieved through semaglutide or tirzepatide therapy.

Cost Access and Insurance Considerations

PlexusDx compounded semaglutide injection begins at $149 per month across all commitment tiers, with the pricing philosophy that your dose may increase but your price won't. No insurance is required, no membership fees apply, and the medications are HSA/FSA eligible—making precision GLP-1 therapy accessible to patients regardless of insurance status or employment situation. All compounds originate from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality.

Patients often discover that PlexusDx pricing is significantly lower than brand-name semaglutide or tirzepatide, especially when compounded formulations suit their clinical needs. The flat-rate model eliminates surprise cost escalations as your prescriber optimizes your dose. For those interested in genetic insights, the Precision Peptide Genetic Test ($99 add-on) provides actionable data to refine medication selection and dosing strategy from month two onward.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What BMI do I need to qualify for GLP-1 medications?

The standard threshold is BMI 30 or higher, or BMI 27+ with a weight-related condition like type 2 diabetes or hypertension. PlexusDx evaluates your complete health profile during intake to confirm medical appropriateness, not just a number.

Can GLP-1 medications help if I don't have diabetes?

Yes. GLP-1 compounds are approved for weight loss in non-diabetic individuals meeting BMI or comorbidity criteria. Many PlexusDx patients use semaglutide or tirzepatide purely for weight management and metabolic health improvement.

How does the Precision Peptide Genetic Test help determine if GLP-1 is right for me?

The test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your response pattern across 14 metabolic pathways. This $99 add-on (after month one) reveals whether you'll respond optimally to semaglutide, tirzepatide, or a dual compound, accelerating your path to success.

What if I'm taking other medications for diabetes or blood pressure?

GLP-1 medications can work alongside most therapies, but dosages may need adjustment—particularly insulin or sulfonylurea medications. PlexusDx providers review all current medications during consultation to ensure safe, coordinated treatment.

Is compounded semaglutide from PlexusDx as safe as the brand-name version?

PlexusDx compounds come from licensed 503A compounding pharmacies meeting strict pharmaceutical standards. While compounded medications are not FDA-approved in the traditional sense, they are manufactured under the same rigorous quality controls as brand products. Your prescriber monitors your response closely.

What if GLP-1 medications don't work for me?

PlexusDx offers multiple compounds—semaglutide, tirzepatide, oral formulations, and dual-compound options—allowing your provider to pivot if your initial choice doesn't deliver the desired response. Genetic testing can guide these adjustments.

Who Should Take GLP-1 Medications for Weight Loss?